children with the long QT syndrome, and determining the optimal forms of treatment.
Methods
The members of the Pediatric Electrophysiology Society (all pediatric cardiologists) were asked to complete a standardized data form for each patient with the diagnosis of the idiopathic long QT syndrome. This diagnosis was based on 1) the presence of a prolonged QT interval (corrected QT [QTcI by the method of Bazett10 of more than 0.44 seconds) and the absence of any other underlying cause such as prematurity, electrolyte disturbance, or central nervous system abnormality; or 2) both a) unexplained syncope, seizure, or cardiac arrest associated with typical inciting events such as exercise or emotion and b) family history of the long QT syndrome. The entry criteria were intentionally wide, according to the criteria of Schwartz,5 to include This was a retrospective analysis of all patients who met any of the above criteria, so the patient did not have to be alive at the time of data collection. The data form sought information on age at presentation, associated findings, symptoms, family history, ECG variables (routine ECG, Holter, and treadmill), electrophysiological testing, treatment, and follow-up. The criteria for treatment effectiveness were generally similar among the institutions: treatment with pharmacological or nonpharmacological therapy was considered "effective" for symptoms if there were no symptoms within 1 year of follow-up if the patient had been followed that long or between the time of presentation and follow-up if the patient had not been followed for 1 year. Patients receiving antiarrhythmic drugs were also evaluated by Holter; treatment was considered effective for antiarrhythmic drugs if there were no ventricular arrhythmias (less than 10 uniform premature ventricular contractions per hour). A patient was judged by the physician as "noncompliant" based on either subjective questioning or objective low blood levels of drugs. The patients, the family history was positive for sudden death in 31%, syncope in 6%, and seizures in 2%. A family history of a prolonged QT interval was present in 39% of the patients (64% of those with a positive family history for a prolonged QT interval also had symptoms, whereas 36% had no symptoms). Because 89% of the patients with a positive family history had been treated and because treatment affected symptoms at follow-up and sudden death, it is difficult to assess family history as an independent risk factor. Despite an equal distribution of males and females in the index patients as well as their brothers and sisters, there was a statistically significant (p<0.01) female predominance in other relatives: 32% had a positive family history for a mother (compared with 8% for a father), 15% for an aunt (compared with 10% for an uncle), and 8% for a grandmother (compared with 4% for a grandfather). The overall ratio of female to male relatives was 1.55:1.
Associated Findings
Hearing loss was present in 4.5% of all the patients. Of the 12 patients, nine were from Europe and three were from the United States; this represented 8.7% of the foreign patients and 1.6% of the US patients (p<0.025). Fifty percent of the deaf patients had a negative family history, 25% had a family history for both deafness and long QT, and 25% had a family history for only long QT.
Congenital heart disease was found in 12% of the patients. The types of congenital heart disease were similar in prevalence to those in children without the long QT syndrome. Noncardiac congenital disease was found in an additional 5% of the patients.
QT Interval at Presentation
The longest QT interval was found in lead II in 82% of the patients; Vs was the longest lead in 6%, V2 in 5%, and V, in 2%. The distribution of QT. is shown in Figure 1 . A normal QT, (0.44 second or less) was found in 6% of those diagnosed with the long QT syndrome; 27% had a corrected QT interval of 0.55 or more, and 13% had a corrected QT interval of 0.60 or more. A QT, at presentation of more than 0.55 was related to serious symptoms at presentation (59% of those with longer QT, had symptoms compared with 36% of those with a shorter QT, p<0.001); younger age at presentation (61% of those with a longer QT-were under 1 month shorter QT, p<0.001), bradycardia on routine ECG (67% of those with the longer QT, had bradycardia compared with 13% of those with a shorter QTc, p<0.001), and ventricular arrhythmias on routine ECG (23% of those with a longer QT. had ventricular arrhythmias compared with 7% of those with a shorter QTc, p < 0.0 ).
ECG and Electrophysiological Variables
Bradyarrhythmias were found on routine ECG before treatment in 20% of the patients. This bradycardia was most often due to sinus bradycardia or junctional escape rhythm; 5% of the patient group had atrioventricular block. The majority (13 of 15) had second-degree atrioventricular block (most often 2:1) with P waves falling on T waves; only two of 287 patients had complete atrioventricular block. Of the 156 patients who had a Holter, 19% had a minimum heart rate that was below the normal for age, and 36% of the 103 patients who had an exercise test had a maximum heart rate lower than the normal for age. Because seven of the patients with atrioventricular block had pacemakers implanted, it is difficult to assess the presence of atrioventricular block as an independent risk factor. The 50 patients who received no treatment are potentially informative because these are the ones who may represent the "natural history" of the syndrome. However, they do not because they clearly had milder forms of the disease. Compared with the patients who did receive treatment, those who did not receive treatment had less serious symptoms at presentation (12% had serious symptoms compared with 55%, p<0.001), less bradycardia on routine ECG (6% compared with 24%,p<0.01), shorter QT, at presentation of less than 0.46 (56% compared with 17%), and higher positive family history (62% versus 35%, p<0.001). Of the 50 patients who were not treated, two died suddenly; both had a positive family history. 
Long QT Syndrome Without Long QT Interval
Of the 287 patients, 17 (6%) had a QT. of less than 0.44 at presentation; six were identified as having the syndrome because of typical "serious" symptoms (four of six also had a positive family history), nine were identified because of a positive family history only, and two were identified because of a long QT, on Holter in the absence of symptoms with a positive family history. In follow-up, two of six patients with serious symptoms continued to have serious symptoms despite treatment. Of the nine patients with a positive family history only, seven were treated, and none had symptoms at followup. Two of nine were not treated, and one of these two had late sudden death. Of the two patients who presented with QT, prolongation on Holter only, neither was treated, and there were no late symptoms on follow-up. Among all 17 patients with normal QT. at presentation, in three, the QT, was found to be more than 0.44 at follow-up; each of these was 0.46 or more. All three of these patients had serious symptoms or sudden death at follow-up, whereas none of the patients in whom the QT remained at less than 0.44 had either symptoms or sudden death at follow-up. The data relating QT, at presentation, medication noncompliance, and probability of sudden death are shown in Figure 4 . For those with extremely long QT, (0.60 or more), the probability of sudden death in patients who were compliant with their medical regimen was 27-44%, and the probability of sudden death for those who were not compliant with their medication regimen was 83-91%. Discussion
Children Compared With Adults
The diagnostic criteria for the long QT syndrome established by Schwartz4 based on studies in adults and children include the "major" criteria of QTc of 0.44 or more, typical symptoms, positive family history, and the minor criteria of bradycardia, hearing loss, typical morphology of T waves, and T wave alternans. He proposed that to be diagnosed as having the syndrome, the patient should have either two major criteria or one major criterion and two minor criteria. Based on the present study, the criteria appear to be generally valid in our population as well. We did not examine T wave morphology due to the subjective nature of this assessment among 26 different investigators. However, we did address the other criteria. On the basis of this study, although it is not possible to establish major and minor criteria, it appears that a small percentage of children SUDDEN DEATH may have the long QT syndrome without the long QT interval. Therefore, it appears reasonable in the assessment of patients for the presence of the long QT syndrome to include typical symptoms and a positive family history. In addition, because 20% of the patients had bradycardia (with 5% having second-degree atrioventricular block rather than the previously reported complete atrioventricular block)12 and 12-24% of the patients had multiform premature ventricular contractions, monomorphic ventricular tachycardia, or polymorphic ventricular tachycardia on routine ECG, Holter, or treadmill testing, the finding of these types of arrhythmias should alert the clinician to the possibility of the long QT syndrome. Because 85% of those with symptoms presented with symptoms during exercise, it also appears that when a child presents with rapid palpitations or syncope during exercise, the long QT syndrome should be suspected.
In comparison with other reported series in adults and children,911'3 the prevalence of congenital heart disease was high in our patients, although congenital heart disease was not statistically related to mortality in this study. This may be a selection bias due to the fact that all the investigators in this study were pediatric cardiologists. It is not known whether these factors were specifically assessed in the other studies because this factor is not mentioned. Because the children who presented at the youngest ages were most likely to die suddenly, this finding would suggest that studies in adults are skewed in favor of those that survived. family history of the long QT syndrome should be treated, despite the lack of symptoms, because a cardiac arrest may be the first symptom. This conclusion can be debated from the standpoint that this will result in a large number of children being treated unnecessarily. This argument should be viewed in light of the data that in this study, 12% of such patients later developed symptoms and 4% had sudden death. As better diagnostic data are developed, this conservative recommendation is likely to be modified.
The observation from this study that both ineffective treatment and noncompliance with previously effective treatment are predictors of symptoms and sudden death could imply that effective treatment may prevent sudden death. However, because 5% of the patients who were thought to be "effectively" treated in our study had sudden death, this raises the question of whether the medicine was truly effective in certain patients or whether the criteria for "effective treatment" should be made more rigorous. We did find that among those who had sudden death, fewer patients had had Holters and treadmill tests performed at follow-up than those who did not die, perhaps suggesting that the use of these tests might be beneficial in the definition of effectiveness.
In our data, propranolol was equal to other P-blockers in providing effective treatment for symptoms and ventricular arrhythmias; there was a similar incidence of late sudden death with these two types of treatment.
Within the group who received 1-blockers other than propranolol, sudden death was not related to the type of other X3-blocker, with no statistically significant difference between nadolol and atenolol. These data are in contrast to a previous report on a smaller number of children. 17 We found that ineffective treatment, especially for symptoms, was a predictor for late symptoms and sudden death. We also found that ineffective treatment with one drug regimen probably predicted ineffective treatment with other drug regimens, and therefore, it appears that if a patient continues to have severe symptoms on one drug regimen, consideration should be given to nonpharmacological treatment such as a pacemaker or left cardiac sympathetic denervation. Recent studies have demonstrated a reduction in symptoms using either technique. '8-20 Because of the large number of confounding variables, it cannot be determined, on the basis of this study, whether the addition of nonpharmacological therapy will prevent sudden death.
On the basis of our study, children with extremely long QTc (more than 0.55-0.60) are at high risk for sudden death. In this small subgroup of patients with the long QT syndrome, the occurrence of sudden death was not related to the presence of continuing symptoms or continuing ventricular arrhythmias. This implies that it may be extremely difficult to predict which of those children with extremely long QT intervals will have sudden death. Although the implantation of a defibrillator appears to be an extreme measure in a child, it may be that in this subgroup of patients with extremely long QT intervals,2' especially if they are not treated effectively or noncompliant, consideration should be given to implantation of a defibrillator to save their lives. Fortunately, this extremely high-risk group is small in number, and the majority of children with the long QT syndrome appear to have a good prognosis as long as they respond to treatment.
